One hypothesis potentially explaining CML relapse is persistence of leukemic stem cells, which are maintained by BCR-ABL-associated signaling pathways, such as the Wnt/β-catenin pathway67. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.